Lifecore Biomedical to Report Financial Results for the Three Months Ended September 30, 2025, on November 6, 2025

Core Viewpoint - Lifecore Biomedical, Inc. will report its financial results for the three months ended September 30, 2025, on November 6, 2025, after market close, followed by a webcast discussion with senior management [1]. Company Overview - Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO) specializing in the development, fill, and finish of sterile injectable pharmaceutical products, including complex formulations [3]. - The company has over 40 years of expertise in manufacturing premium, injectable-grade hyaluronic acid and serves global and emerging biopharmaceutical and biotechnology companies across various therapeutic categories [3].